IGF-1 LR3
IGF-1 LR3 is a long-acting variant of insulin-like growth factor 1 designed to remain active in your bloodstream for hours rather than minutes, delivering sustained muscle-building, fat-burning, and anti-aging effects. The “LR3” refers to a structural modification that extends its half-life dramatically, allowing one injection to provide extended anabolic signaling throughout your body.
Route
Subcutaneous injection
Dose range
100 mcg
Frequency
Once per day (subcutaneous)
Cycle length
4–8 weeks

IGF1-LR3 1MG
Third-party tested, lot traceable, ships in 3–5 business days.
Overview
IGF-1 LR3 is a long-acting variant of insulin-like growth factor 1 designed to remain active in your bloodstream for hours rather than minutes, delivering sustained muscle-building, fat-burning, and anti-aging effects. The “LR3” refers to a structural modification that extends its half-life dramatically, allowing one injection to provide extended anabolic signaling throughout your body. It stimulates protein synthesis aggressively, boosts satellite cell activation for muscle repair, inhibits myostatin (the natural brake on muscle growth), and accelerates lipolysis for fat loss while preserving muscle—a rare combination that separates it from most peptides.
Benefits span lean muscle gain, improved recovery speed post-workout, enhanced bone density, joint support through anti-inflammatory effects, and cardiovascular improvements through better endothelial function. Users report fuller muscles, defined abs, sustained energy, and improved athletic performance within weeks. It’s particularly valuable for competitive athletes, older adults combating sarcopenia, or anyone recovering from injury wanting to preserve or rebuild muscle while optimizing body composition. The sustained action means fewer injections needed compared to natural IGF-1. Injected systemically or locally to specific muscles, IGF-1 LR3 offers direct growth hormone-independent anabolic signaling for dramatic muscle and performance enhancement backed by research.
Studied benefits
- A potent analog of IGF-1 with an extended half-life
- it provides powerful anabolic signaling and enhances protein synthesis in target tissues
- It is widely used in research for its ability to drive growth through the IGF-1 receptor
Reported side effects
- High risk of hypoglycemia (low blood sugar)
- symptoms include dizziness, sweating, and confusion
- It is critical to consume food during administration
- Continuous use can lead to receptor desensitization, necessitating cycling
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
IGF-1 LR3 (1mg)
Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~333 mcg/mL).
Support anabolic processes and metabolic function through enhanced IGF-1 activity with extended bioavailability.
IGF-1 LR3 + PEG-MGF (1mg/2mg Blend)
Reconstitute with 2.0 mL bacteriostatic water (Conc: 0.5 mg/mL IGF | 1.0 mg/mL MGF).
Support systemic anabolism (IGF-1) and localized muscle cell hyperplasia (PEG-MGF).
| Week | IGF Dose (mcg) | Draw at 0.33 mg/mL | Log |
|---|---|---|---|
| Units (mL) | Weeks 1–4 | 40 mcg | + Log |
| 80 mcg | 8 units (0.08 mL) | Weeks 5–8 | + Log |
| 50 mcg | 100 mcg | 30 units (0.3 mL) | + Log |
Frequency
Once per day (subcutaneous).
Timing
Post-workout or morning on rest days.
Cycle length
4–8 weeks.
Unit calculator
Set your vial and water; the table above updates.
0.33 mg/mL
10 doses of 100 mcg per vial
At the starting dose (100 mcg × 7/week for a 4-week cycle) you would use about 2.8 mg, i.e. 3 × 1 mg vials. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a high-protein, balanced diet to provide a steady supply of nutrients for the prolonged anabolic window created by this long-acting analog of insulin-like growth factor-1. Follow a consistent resistance training program to leverage the peptide’s ability to enhance nitrogen retention and muscle protein synthesis over an extended period. Ensure 7–9 hours of quality sleep for systemic recovery and hormonal balance. Due to its long half-life, periodically monitor fasting blood glucose and insulin sensitivity markers to ensure metabolic health is maintained while the peptide facilitates systemic growth and cellular repair.
Evidence
Research summaries
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
Findings: Builds bigger muscles by boosting protein making and cutting muscle breakdown, great for staying strong as we age.
IGF-1 LR3 is a longer-lasting version of a natural muscle-growing signal in our bodies. Scientists found it turns on paths inside muscle cells that ramp up building new proteins while shutting down the ones that chew up old muscle. In lab tests on animal muscles, it made fibers thicker and stronger, fighting off weakness from not eating or getting old. This means it could help people recover from bed rest or injuries by keeping muscles from shrinking, without messing with sugar levels too much. It's like a workout helper that works right where muscles need it.
Read the study ↗IGF-1 induces human myotube hypertrophy by increasing protein synthesis
Findings: Grows human muscle cells bigger in dishes, promising for muscle repair therapies.
Researchers grew human muscle starter cells and turned them into tubes like real muscles. Adding IGF-1 (and its LR3 form acts even stronger) made these tubes swell up by cranking protein factories inside. It didn't make more cells but fattened the ones there, mimicking how lifting weights grows biceps. No big side effects in the dish, hinting LR3 could speed healing after surgeries or for folks losing muscle to diseases like muscular dystrophy. Safe local growth without whole-body changes makes it kid-friendly to understand as muscle magic.
Read the study ↗IGF1 stimulates greater muscle hypertrophy in the absence of myostatin
Findings: Supercharges muscle growth when paired with natural muscle builders, cuts body fat too.
Myostatin is like a brake on muscle size, and IGF-1 LR3 hits the gas. In mice without that brake, LR3 made muscles explode in size—more fibers and thicker ones—plus less fat around organs. It worked through signals like AKT that tell cells to grow and store energy right. For humans, this combo could treat muscle-wasting sicknesses or help athletes bulk safely. Studies showed better fiber types for power, explaining why it feels energizing without jitters.
Read the study ↗Recombinant expression of IGF-1 and LR3 IGF-1 fused proteins
Findings: Creates stable, long-acting versions for extended muscle support.
Scientists engineered IGF-1 LR3 in labs to last longer in blood and stay active. These lab-made versions kept their muscle-building punch for hours instead of minutes. Makes dosing easier and more practical for treatments. Like upgrading your body's own signal to work overtime without extra shots.
Read the study ↗Identification
Chemistry
- cas
- 946870-92-4
- formula
- C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₉
- molecular weight
- 9117.5 Da (or 9.12 kDa)
- sequence
- MFPAMPLLSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMY CAPLKPA KSA
- source
- Synthetic; recombinant DNA-derived; produced via bacterial (Escherichia coli) protein expression systems
- biosynthesis
- Ribosomal origin (expressed from recombinant DNA construct); nonribosomal modifications applied post-translationally
- type
- Linear peptide with three disulfide bonds formed between cysteine residues (similar to native IGF-1)
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
AHK-Cu
GHK-Cu · Copper Tripeptide-1
- Route
- Topical
- Dose
- —
- Cycle
- —
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
B7-33
B7-33 peptide · RXFP1 agonist B7-33
- Route
- Subcutaneous
- Dose
- 150 mcg – 500 mcg
- Cycle
- 4–8 weeks for acute fibrosis studies